Company: SXTPW
Filing Date: 2025-03-27
Form Type: S-1/A
Source: 0001013762-25-003353
Chunk: 202

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: S-1/A
Chunk 202
---
 facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. The selling stockholders may use any one or more of the following methods when selling securities:

| ● | ordinary brokerage transactions                                  
 and transactions in which the broker-dealer solicits purchasers; |

| ● | block trades in which the                                                                                                                
 broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate 
 the transaction;                                                                                                                         |

| ● | purchases by a broker-dealer                                  
 as principal and resale by the broker-dealer for its account; |

| ● | an exchange distribution                                 
 in accordance with the rules of the applicable exchange; |

| ● | privately negotiated transactions; |

| ● | settlement of short sales; |

| ● | in transactions through                                                                                                                   
 broker-dealers that agree with the selling stockholders to sell a specified number of such securities at a stipulated price per security; |

| ● | through the writing or                                                                                 
 settlement of options or other hedging transactions, whether through an options exchange or otherwise; |

| ● | a combination of any such 
 methods of sale; or       |

| ● | any other method permitted  
 pursuant to applicable law. |

The selling stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act, if available, rather than under this prospectus. Broker-dealers engaged by the selling stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the selling stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in compliance with FINRA Rule 2121. In connection with the sale of the securities or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The selling stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The selling stockholders may also enter into